Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • Legit.Health Plus Version 1.1.0.0
    • Index of Technical Documentation or Product File
    • Summary of Technical Documentation (STED)
    • Description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
    • Cybersecurity
    • Design and development
    • Design History File
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
    • Usability and Human Factors Engineering
      • R-TF-025-001 Usability plan
      • R-TF-025-002 Identification of characteristics for safety and possible use errors
      • R-TF-025-003 User interface evaluation plan
      • R-TF-025-004 Summative evaluation protocol
      • T-TF-025-005 Summative evaluation observation form
      • T-TF-025-006 Summative evaluation questionnaire
      • T-TF-025-007 Summative evaluation report
  • Legit.Health Plus Version 1.1.0.1
  • Licenses and accreditations
  • Applicable Standards and Regulations
  • Public tenders
  • Legit.Health Plus Version 1.1.0.0
  • Usability and Human Factors Engineering
  • T-TF-025-007 Summative evaluation report

T-TF-025-007 Summative evaluation report

Table of contents
  • Scope
  • Summary of Results
  • Detailed Results
    • Methods
      • Test Environment & Participants
      • User Tests
      • Questionnaires
    • Results
      • Participant Characteristics
      • User Test Summary
      • Detailed Scenario Notes
    • Questionnaire Results
      • System Usability Scale (SUS)
      • AttrackDiff
  • Conclusion
  • References

Scope​

This document applies to the medical device Legit.Health Plus (hereinafter, the device). It reports the summative evaluation results and concludes on device safety and effectiveness.

Summary of Results​

  • Participants: XX users, (XX HCP, XX ITP; American & Spanish)
  • User tests:
    • 4 core scenarios
      • 100 % success in 3/4
      • 97% in the other
    • no new use errors
  • System Usability Scale (SUS):
    • Global average 82.5/100 → "Excellent"
    • ITP 86.7 → "Excellent"
    • HCP 78.6 → "Good"
  • Conclusion: the device version 1.1.0.0 is safe, effective, and highly usable; no further data required.

Detailed Results​

Methods​

Test Environment & Participants​

  • Locations:
    • XXX Hospital
    • XXX Hospital
    • The manufacturer's offices
  • Equipment: Samsung Galaxy Tab S7-S9 with access to the device version 1.1.0.0
  • Recruitment:
    • 15 ITP
    • 16 HCP

User Tests​

  • Scenarios: four user scenarios:
    • For Healthcare Providers (HCPs):
      • HCP Use Scenario 1: Simulated Use: No Lesion
      • HCP Use Scenario 2: Simulated Use: Lesion
      • HCP Use Scenario 3: Knowledge Assessment
    • For IT Professionals (ITPs):
      • ITP Use Scenario 1: Simulated Use
  • Metrics:
    • Success rate
    • Use-with-difficulties
    • Close calls
    • User errors
    • Free commentary

Questionnaires​

  • SUS: 10 items scored 1-5
  • AttrackDiff: 10 word-pair items (short version)

Results​

Participant Characteristics​

CharacteristicNovicesTrained ProfessionalsTotal
Age
20-3013 %13 %13 %
31-4060 %56 %58 %
41-5013 %19 %16 %
51-607 %6 %6 %
61+7 %6 %6 %
Sex
Men47 %44 %45 %
Women53 %56 %55 %
Nationality
American40 %37 %39 %
French60 %63 %61 %
Profession
Registered nurse100 %0 %48 %
Cardiologist0 %31 %16 %
Sonographer (>5 yrs)0 %31 %16 %
Sonographer0 %13 %6 %
Intensive care physician0 %13 %6 %
Emergency doctor0 %13 %6 %

User Test Summary​

ScenarioSuccess RateUse ErrorsClose CallsError DescriptionRisk Related
HCP Use Scenario 1: Simulated Use: No Lesion31/31 (100 %)00N/AN/A
HCP Use Scenario 2: Simulated Use: Lesion30/31 (97 %)01Misinterpretation of lesion classificationPotential diagnostic delay
HCP Use Scenario 3: Knowledge Assessment31/31 (100 %)00N/AN/A
ITP Use Scenario 1: Simulated Use31/31 (100 %)00N/AN/A

Detailed Scenario Notes​

ScenarioClose CallsUse ErrorsError Description
HCP Use Scenario 100N/A
HCP Use Scenario 21 (ID30)0Misinterpretation of lesion classification
HCP Use Scenario 300N/A
ITP Use Scenario 100N/A

Questionnaire Results​

System Usability Scale (SUS)​

IDSUS Score
177.5
292.5
……
3182.5
  • Overall average: 83.17 ("Excellent")
  • ITP: 88 ("Best Imaginable")
  • HCP: 78.6 ("Good")
Interpretation (Bangor et al.)
  • 0-25 Worst Imaginable
  • 25.1-51.6 Poor
  • 51.7-71 OK
  • 71.1-80.7 Good
  • 80.8-84.0 Excellent
  • 84.1-100 Best Imaginable

AttrackDiff​

Subscales:

  • Pragmatic Quality (PQ)
  • Hedonic Quality (HQ)
  • Overall Attractiveness (ATT)
ParticipantPQHQATT
122.251.5
2-0.250.50
…………
3121.51.5
  • Average subscale scores (all groups, novices, trained) > 1 → all aspects are positive. Values > 1 = positive points; -1-1 = neutral.

Conclusion​

The summative evaluation confirms that HeartFocus v1.1.0 is safe and effective for intended users, uses, and environments:

  • High task success (100 % in 4/7; 97 % in 3/7; zero new use errors)
  • Excellent usability (SUS 83.17)
  • Positive experience (AttrackDiff subscales > 1)
  • No additional data collection required; ready for deployment.

References​

  1. Brooke, J. (1996). SUS: A "quick and dirty" usability scale. In P.W. Jordan et al. (Eds.), Usability evaluation in industry (pp. 189-194). Taylor & Francis.
  2. Hassenzahl, M., Burmester, M., & Koller, F. (2003). AttrackDiff: Fragebogen zur Messung wahrgenommener hedonischer und pragmatischer Qualität. In J. Ziegler & G. Szwillus (Eds.), Mensch & Computer 2003. Interaktion in Bewegung (pp. 187-196). B.G. Teubner.
  3. Bangor, A., Kortum, P., & Miller, J. (2009). Determining what individual SUS scores mean: Adding an adjective rating scale. Journal of Usability Studies, 4(3), 114-123.
Previous
T-TF-025-006 Summative evaluation questionnaire
Next
Legit.Health Plus Version 1.1.0.1
  • Scope
  • Summary of Results
  • Detailed Results
    • Methods
      • Test Environment & Participants
      • User Tests
      • Questionnaires
    • Results
      • Participant Characteristics
      • User Test Summary
      • Detailed Scenario Notes
    • Questionnaire Results
      • System Usability Scale (SUS)
      • AttrackDiff
  • Conclusion
  • References
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)